For US residents only.


Know Now Users!

The Know Now BRAF Testing Program has concluded, effective April 30, 2022. Novartis remains committed to expanding awareness of BRAF testing. For additional information on melanoma and BRAF mutations, please visit our site.


Use of website is governed by the Terms of Use and Privacy Policy.

Copyright © 2022 Novartis Pharmaceuticals Corporation. All rights reserved.

4/22 203941